Literature DB >> 9851284

Risk factors for thrombotic events in giant cell arteritis and polymyalgia rheumatica.

B Seriolo, M Cutolo, A Garnero, S Accardo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9851284     DOI： 10.1093/rheumatology/37.11.1251

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN： 0263-7103


× No keyword cloud information.
  5 in total

1.  Prevalence of the antiphospholipid syndrome in primary systemic vasculitis.

Authors:  J D Rees; S Lança; P V Marques; J A Gómez-Puerta; R Moco; C Oliveri; M A Khamashta; G R V Hughes; D P D'Cruz
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

2.  The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.

Authors:  J Antonio Aviña-Zubieta; Vidula M Bhole; Neda Amiri; Eric C Sayre; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2014-09-29       Impact factor: 19.103

Review 3.  Thromboembolic disease in vasculitis.

Authors:  Gunnar Tomasson; Paul A Monach; Peter A Merkel
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

Review 4.  The thromboembolic risk in giant cell arteritis: a critical review of the literature.

Authors:  A Guida; A Tufano; P Perna; P Moscato; M T De Donato; R Finelli; D Caputo; M N D Di Minno
Journal:  Int J Rheumatol       Date:  2014-05-20

5.  Thrombosis in vasculitis: from pathogenesis to treatment.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Amedeo Amedei; Elena Niccolai; Mario Milco D'Elios; Chiara Della Bella; Alessia Grassi; Matteo Becatti; Claudia Fiorillo; Lorenzo Emmi; Augusto Vaglio; Domenico Prisco
Journal:  Thromb J       Date:  2015-04-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.